Sequence-specific DNA binding factors are involved in the control of various cellular processes, such as control of gene expression and DNA replication (1) (2) (3) (4) (5) (6) (7) (8) (9) . Eukaryotic DNA replication initiates from multiple origins. In yeast, a large number of isolated DNA sequences, termed autonomously replicating sequences (ARSs), have been shown to be the origins of chromosomal DNA replication in vivo (10) (11) (12) (13) (14) and Francesconi and Eisenberg (15) have reported the identification and purification of origin binding factor 1 (OBF1) that binds to a sequence in the telomeric ARS120, ARS131C, and ARS131L. It also binds ARSI, somewhat weaker.
To further explore the roles of various ARS binding factors in DNA replication and gene expression, we have cloned and characterized the gene for OBF1.
MATERIALS AND METHODS
Strains, Bacteriophage and Plasmid Libraries, and Antisera. Saccharomyces cerevisiae genomic DNA library in Agtll was a gift from Michael Snyder of Yale University and in YEp24 was a gift from Marian Carlson of Columbia University. S. cerevisiae strain BJ2168 was from the yeast genetic stock center, University of California at Berkeley. Antiserum was prepared against partially purified OBF1 protein and immunoaffinity-purified using either gel-purified 130-kDa OBF1 protein or recombinant A bacteriophage-encoded fusion protein.
Synthetic Oligonucleotides. The oligonucleotides used in this study were as follows: El, 5'-GATCCAATACATCAT-AAAATACGAACGA-3', derived from HMRE-ARS (2); F1, 5'-GATCCAAGTGCCGTGCATAATGATGTGGG, derived from the OBF1 recognition sequence in ARS120 (14) ; and other oligonucleotides were as described (2) . Oligonucleotides El and F1 bind to OBF1 or OBF1-like factors in the yeast nuclear extract (25) (17) . Screening was carried out with catenated and nick-translated oligonucleotide Fl. Lysogens of the isolated recombinants were prepared by the protocol of Snyder et al. (18) . Induction and preparation of fusion proteins were carried out by the method of Singh et al. (16) . The extracts were dialyzed against a buffer containing 50 mM Tris HCl (pH 7.5), 1 mM EDTA, 5 mM MgCl2, 1 mM dithiothreitol, 20% (vol/vol) glycerol, pepstatin A (5 ,ug/ml), leupeptin (5 ,g/ml), and 0.02% Nonidet P-40 for 1-2 hr at 4°C, divided into portions, and stored frozen at -80°C until further use. YEp24 yeast genomic DNA library was screened with the radiolabeled 3.2-kilobase (kb) insert DNA from the AA2 recombinant phage (5, 19) .
Mobility-Shift DNA Binding Assays. The mobility-shift DNA binding assays were carried out as described (2) .
Northern, Southern, and Contour-Clamped Homogeneous Electric Field (CHEF) Analysis. Northern and Southern blot analyses were carried out following published methods (19 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. 2.5 x 1W independent recombinants using sequence-specific oligonucleotide binding as the screening method (8, 16, 17) . Nine clones were isolated in the initial screening and two of these nine clones were found to be repeatedly positive in three consecutive screenings. The results of the third screening with two positive clones and one negative clone are shown in Fig. 1 A and B. Both of these clones produced positive signals when screened with oligonucleotide F1 or EL. These two positive clones (AA1 and AA2) were identical in the insert DNA size (3.2 kb) and restriction map. The restriction map of the AA2 clone is shown in Fig. 1C . The 3.2-kb insert DNA was used to probe a yeast genomic DNA library in YEp24 and three independent clones were isolated. Each contained the entire putative gene for OBF1 and its 5' and 3' adjacent sequences. The restriction map of a 6.8-kb DNA fragment containing the complete gene for OBF1 and its 3' and 5' regions (EB103) is shown in Fig. 1C .
Northern blot analysis of yeast poly(A)+ RNA with a radiolabeled 3.2-kb insert DNA indicated that a single -3.8-kb mRNA hybridized to the probe ( Fig. 2A) (Fig. 2E) . Two additional polypeptides of lower molecular mass were also detected that appeared to be protease-degraded forms of OBF1, because levels of these low molecular mass bands increased with storage of the extract.
Binding of the Fusion Protein to OBFl-Specific Oligonucleotides. The DNA binding properties and specificities of the fusion protein in the extract were analyzed by mobility-shift DNA binding assays using synthetic and native DNA sequences. Binding of the fusion protein to labeled oligonucleotides EI and F1 is shown in Fig. 3A . The fusion protein bound to both oligonucleotides with high specificity. In addition, oligonucleotide EI or F1 could inhibit the binding of the other to the fusion protein. To determine the specificity of binding, we analyzed other oligonucleotides as competitors of oligonucleotide F1 binding and the result is shown in Fig. 3B . Oligonucleotides EI and F1 acted as specific competitors of binding but oligonucleotides CEN and EII, specific for the centromere binding protein (20) and general regulation factor I (2), respectively, did not inhibit the binding. However, the binding of the fusion protein to oligonucleotide F1 was inhibited by a 237-bp fragment containing the domain B of ARSJ (Fig. 3C) . Oligonucleotide mtla, a mutant form of the EI sequence (2) , weakly inhibited the binding. Thus the fusion protein binding to oligonucleotides EI and F1 appeared to be sequence-specific.
Binding of the Fusion Protein to Domain B of ARS). The fusion protein tightly bound a 237-bp HindIII-Bgl II fragment of ARSJ that contains domain B. A titration of fusion protein binding is shown in Fig. 4A (Fig. 4B) indicated that fusion protein protected a region of ARSI that was similarly protected by OBF1 of yeast. The protected region (shown in the bracket in Fig. 4B ) was in domain B of ARSJ. Protection was observed between the nucleotide 750 and nucleotide 780 of ARSJ (21, 22) .
Thus, the fusion protein from the recombinant bacteriophage contained the DNA binding epitope of yeast OBF1 and displayed identical DNA binding characteristics and specificities. In addition, the isolation gene coded for a protein that corresponded to the reported size of OBF1 (15) and crossreacted with an OBF1 antibody.
DISCUSSION
We have isolated the gene for an ARS binding factor by screening a yeast genomic DNA library in Agtll with synthetic recognition sequences of OBF1. We have isolated the complete gene by screening a yeast genomic DNA library in YEp24 plasmid and the restriction map of the gene is shown in Fig. 1C . Northern blot analysis with an isolated 3.2-kb insert DNA of the AA2 clone indicated that the mRNA is -3.8 kb, which could encode a protein of -130 kDa. The reported size ofthe purified OBF1 is -130 kDa (15) . Southern blot analysis of restriction enzyme-digested yeast chromosomal DNA (Fig. 2C ) indicated that the gene is a single-copy gene. Pulsed-field CHEF electrophoresis of yeast chromosomes and Southern blot analysis indicated that this gene is located in chromosome IV.
A polyclonal antibody, affinity-purified using the AA2 fusion protein, detected a 130-kDa polypeptide in Western blot analysis of yeast extract (Fig. 2E) , confirming that the sizes of the gene-encoded polypeptide and the native OBF1 are identical. The recombinant-encoded fusion protein bound two synthetic OBF1 recognition sequences, oligonucleotides El and F1, with high specificity (Fig. 3) . The fusion protein bound the 237-bp DNA fragment encoding domain B ofARSI with high specificity (Fig. 4A) . The footprinting analysis carried out with the 237-bp domain B fragment indicated that the binding of the fusion protein was highly specific and the protection was extracted in the OBF1 binding site (Fig. 4B) . Thus, the fusion protein from the recombinant bacteriophage contained the DNA binding epitope of OBF1 and displayed identical DNA binding characteristics and specificities.
Thus these results established that the isolated gene coded for the yeast origin binding factor OBF1. Further studies should allow analysis and comparison of the genetic and biochemical characteristics of OBF1 and other factors, such as ARS binding factor I, with similar DNA binding properties and mutational analysis of the protein (23, 24 
